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Abstract A convenient and economical method is described for 
the site-specific “N-1abelling of the 4-amino group of individual 
cytidine residues in oligonucleotides. This is applied to a 20 base- 
pair oligonucleotide corresponding to the trp operator; this ol- 
igonucleotide and its complex with the E. coli trp repressor are 
studied by NMR, using ‘H-“N HMQC and “N-edited ‘H-‘H 
NOESY experiments. 
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1. Introduction 
The use of stable isotopes (‘H, 13C, 15N) incorporated biosyn- 
thetically is well established as an invaluable aid to the resolu- 
tion and assignment of protein NMR spectra [ 1,2]. By growing 
E. coli cells in appropriate media, it is possible to label the 
protein either uniformly or selectively with the desired isotope 
(e.g. [3-61). Recently, RNA molecules isotopically labeled with 
13C and/or 15N have been successfully produced by using la- 
beled nucleotides isolated from ribosomal RNA of E. coli cells 
grown in media containing [“Clglucose and/or ‘5NH,Cl [7,8]. 
The availability of such labeled RNAs has made it possible to 
use NMR for detailed studies of the conformation of function- 
ally important RNA motifs [9,10]. 
The isotopic labelling of oligodeoxyribonucleotides for 
NMR still depends on total chemical synthesis [ 11,121. A signif- 
icant advantage of chemical synthesis over biosynthetic meth- 
ods is that labelling of the oligonucleotide can be achieved in 
a site specific manner, leading to unambiguous NMR reso- 
nance assignments [13-l 51. In addition, the specific isotopic 
label on the oligonucleotide can be very valuable in studies of 
its interaction with another molecule such as protein or drug 
by using isotope-edited NOE experiments [16]. Although chem- 
ical methods have been available for a number of years [ 171, 
they have not found general and routine application due to the 
complexity of the chemical synthesis. 
In view of the high costs involved in the preparation of 
sufficient quantities (- 5 mg) of pure DNA oligomer, in addition 
to the expensive isotope used for labelling, it is necessary to 
develop an economical route to the synthesis of isotopically 
labelled DNA oligomers. In this communication we report the 
application of a simple procedure [l&19] for introducing 15N 
isotopic labels at the 4-position of any specified cytosine. The 
*Corresponding author. Fax: (44) (116) 525526. 
synthetic approach depends on the fact that it is relatively easy 
to introduce a leaving group such as the triazolo group onto 
the 4-position of pyrimidines and subsequently replace it with 
ammonia. While this paper was in preparation, a similar chem- 
ical approach to “N labelling was reported by Acedo et al. [ 151. 
We have used this method to “N label the exocyclic amino 
nitrogen (N4) of cytidine C(-6) in a 20 bp oligodeoxyribonu- 
cleotide corresponding to a consensus trp operator (the num- 
bering starts at the centre of the palindromic sequence, with 
bases in the 5’ direction being given negative numbers): 
d 5’-CGAACJAGTTAACTAGTTCG-3’ 
We chose to introduce the label at this position because the 
complementary base G6 plays a role in the specificity of the 
interaction between this operator sequence and the trp re- 
pressor [20], forming a water-mediated hydrogen bond to the 
protein as illustrated in Fig. 1. 
C76 
Fig. 1. The environment of the G(6)-C(-6) base pair of the trp operator 
in its complex with the trp repressor, as seen in the crystal structure of 
the complex [20]. 
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Fig. 2. (A) “N-edited ‘H-‘H NOESY spectrum (mixing time 100 ms) of specifically ‘5N-labelled DNA in 90% H,O + 10% ‘H,O, recorded at a ‘H 
frequency of 600 MHz, and a sample temperature of 300K. The one-dimensional ‘H spectrum is shown along the Fl dimension for reference. 
(B) Conventional ‘H-‘H NOESY spectrum of unlabelled DNA recorded under the same experimental conditions. 
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2. Materials and methods 
2.1. DNA synthesis and purljication 
Synthesis of the oligodeoxynucleotide containing “N-labeled cyto- 
sine was carried out using a modification of the method previously 
described [18]. In brief, the oligonucleotide was synthesized on an 8.5 
micromol scale using an automated DNA synthesizer (Applied Biosys- 
terns 391), using Expedite amidites of the normal bases and Expedite 
guanine CPG-support (from Millipore). The portion of the oligonucle- 
otide 3’ to the modified cytosine was synthesized on the machine, then 
a versatile monomer S-O-(4,4’-dimethoxytriphenylmethyl)-4-triazolo- 
2’-deoxyuridine-3’-O-(2-cyanoethyl-N,N-diisopropyl)-phosphoramid- 
ite was added manually as follows. 50 mg of the required monomer 
(synthesized in our laboratory or purchased from Glen Research, USA) 
was dissolved in 0.5 ml of anhydrous CH,CN and 0.5 ml of 0.5 M 
tetrazole in anhydrous CH,CN added. The bottom end of the cartridge 
containing the support with the partially synthesized oligomer attached 
was disconnected from the machine and the solution of monomer and 
tetrazole injected from a gas tight syringe. The syringe was used to draw 
the solution in and out of the cartridge several times over a period of 
5 min, and the cartridge was then immediately reconnected to the 
synthesizer and the synthesis completed. 
After synthesis, the CPG-suppoit bearing the synthetic oligomer was 
transferred to a tube. to which 2 ml of 6 M 15N-ammonia (ISOTEC Inc.. 
USA) was added. The tube was tightly sealed, occasionally shaken and 
left for 36 h at 25°C to cleave the oligomer from the support, remove 
all protecting groups and to substitute the 4-triazolo function with 
15NH, to produce the desired (N4-‘5N)-cytosine at position -6. Reaction 
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Fig. 3. 15N-‘H correlated HMQC spectra, recorded at a sample temper- 
ature of 300K. (A) Free “N-1abelled oligonucleotide; (B) 15N-labelled 
oligonucleotide in its 1: 1 complex with E. coli trp repressor. 
at this moderate temperature minimises the possibility of hydrolysis of 
the 4-triazolo group to yield uracil. 
The product was purified by using a Nensorb (DuPont) nucleic acid 
purification cartridge (8 columns) according to the manufacturers pro- 
tocol. The resultant oligomer was checked by FPLC [19]; this chroma- 
tography can clearly distinguish the oligomer containing converted 
base (i.e. “N-cytosine) from that containing hydrolysed base (i.e. ura- 
cil). The latter was the most probable impurity, but was not detected 
in the chromatograph. About 500 OD units of pure oligonucleotide 
were obtained, corresponding to a 20% isolated yield based on the first 
nucleoside attached to the CPG support. 
2.2. NMR sample preparation 
Prior to NMR experiments, the labeled oligonucleotide was heated 
to 85°C for about 5 min and then very slowly cooled down to about 
5°C (overnight) to ensure duplex formation. The sample contained 
2 mM 15N-labeled oligonucleotide, 20 mM sodium phosphate, 50 mM 
NaCl, pH 6.4, in 90% H,O/lO% ‘H,O. E. colifrp repressor (isolated and 
purified as described previously [5]) was added to give a 1: 1 complex. 
2.3. NMR spectroscopy 
NMR spectra were obtained using a Bruker AMX 600 spectrometer, 
operating at a ‘H frequency of 600 MHz. Spectra were measured at a 
sample temperature of 300K, using a spectral width of 13.2 kHz and 
with the carrier frequency on the water resonance. The intense signal 
from the water protons was minimised either by presaturation or by 
using the ‘jump and return’ pulse sequence [21] with a delay of 50 ps. 
Phase sensitive NOESY spectra were recorded with 2K complex points 
(t2) and 256 time increments (t,), each FID being averaged over 128 
transients. 
Two dimensional 15N-‘H HMQC spectra [22] were measured with the 
double-quantum delay set to the calculated value of 1/2J = 5.6 ms in 
the case of the free oligonucleotide, but optimised to a lower value of 
4.2 ms in the case of the oligonucleotide-protein complex. The GARP 
pulse sequence was employed for ‘5N-decoupling. The “N-edited ‘H-‘H 
NOESY experiment was implemented as described previously [23]. 
Proton and nitrogen chemical shifts of the spectra were calibrated with 
reference to the signals of dioxane and ammonium nitrate, serving as 
internal and external standards, respectively. 
3. Results and discussion 
The proton-decoupled “N-spectrum of the labeled oligonu- 
cleotide shows only a single peak at 74.72 ppm (data not 
shown), confirming the specificity of the “N labelling. The 
“N-edited ‘H-‘H NOESY spectrum of the site-specifically “N- 
labeled oligonucleotide is compared with the normal NOESY 
spectrum of the unlabelled material in Fig. 2 (spectra A and B, 
respectively). The considerable spectral simplification achieved 
by the labelling is evident from this comparison. 
In the spectrum of the labeled oligonucleotide (Fig. 2A), the 
signals at 7.86 and 6.52 ppm (labeled a and b) correspond to 
the two 4-amino protons of the uniquely 15N-labeled cytosine 
C(-6). These resonances can be individually assigned on the 
basis of their NOES. In addition to the strong NOE between 
the two amino protons themselves, there is an NOE cross-peak 
between resonance b and a signal at 5.06 ppm, which can be 
assigned to H5 of the cytidine base. The characteristic proton 
chemical shifts of oligodeoxyribonucleotides in the B-DNA 
type conformation [24,25] suggest that the lower-field reso- 
nance, a, is likely to arise from the amino proton which is 
involved in the Watson-Crick hydrogen-bond. This is con- 
firmed by the observation of an NOE cross-peak between res- 
onance a and an imino proton resonance at 12.65 ppm, which 
must arise from the imino proton of G(6). 
The “N-‘H HMQC spectra of the labeled oligonucleotide in 
its free state (A) and when bound to the trp repressor (B) are 
64 V. Ramesh et al. IFEBS Letters 363 (1995) 6144 
shown in Fig. 3. There is no significant change in ‘H or 15N 
chemical shift of this amino group on binding to the protein. 
However, the resonance linewidths are substantially increased, 
with the hydrogen-bonded proton (a, 7.86 ppm) showing a 
greater line-broadening than the non-hydrogen bonded one 
(b, 6.52 ppm). 
This selective broadening cannot arise simply from the in- 
crease in overall rotational correlation time of the molecule on 
complex formation. This has a parallel in the line-broadening 
observed for the backbone peptide NH protons in the spectra 
of selectively labeled 15N-trp R on binding to the operator 
oligonucleotide [5]. Here the broadening selectively affects 
amino acid residues in the N-terminal segment and, notably, in 
the DNA-binding helix-turn-helix domain. These selective 
changes in linewidth imply the existence of some dynamic proc- 
ess(es) within the complex, affecting those residues in each 
partner which are close to the site of interaction. We are pres- 
ently carrying out additional labelling experiments to confirm 
and extend this observation. 
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